期刊文献+

气管切开术后肺部感染的病原学分析及防治 被引量:2

Etiology and treatment of patients with lung infection after tracheotomy
原文传递
导出
摘要 目的归纳总结气管切开术后肺部感染的病原学特点。方法回顾我院气管切开术后发生肺部感染的245例患者资料,对其痰细菌培养、药敏试验结果及临床资料进行分析。结果气管切开患者发生肺部感染率为83.6%;共分离出334株病原菌,G-杆菌224株占67.1%。感染率最高的病原菌依次为:铜绿假单胞菌(23.4%)、金黄色葡萄球菌(17.4%)、克雷伯氏菌属(11.7%)、不动杆菌属(10.5%)、大肠埃希菌(9.6%)。药敏结果显示:所选抗菌药物中,对G-杆菌敏感性较高的药物有亚胺培南(73.7%),哌拉西林/他唑巴坦(61.1%),对G+球菌敏感性较高的药物有万古霉素(100%),呋喃妥因(92.9%)。产超广谱β-内酰胺酶的G-菌和耐甲氧西林的金黄色葡萄球菌出现的耐药率呈现上升趋势(P<0.05)。结论气管切开术后肺部感染主要病原菌为G-杆菌,部分细菌的耐药率明显增加,应积极开展痰细菌培养及药敏试验,合理使用抗菌药物,以减少耐药菌株的产生。 Objective To study the etiological characteristic of patients with lung infection after tracheotomy.Methods The results of germiculture,the drug sensitivity from phlegm and the clinical data of 245 patients with lung infection after tracheotomy from January 2008 to December 2010 were reviewed.Results The incidence rate of iatrogenic infection of lung was 83.6%.334 strains of pathogenic bacteria were isolated,of which 224 strains of Gram-negative bacilli accounted for 67.1%.The pathogens consisted of Pseudomonas aeruginosa(23.4%),Staphylococcus aureus(17.1%),Klebsiella pneumoniae(11.7%),Acinetobacter baumannii(10.5%),and Escherichia coli(9.6%).The drugs sensitive to Gram-negative bacilli were imipenem(73.7%) and piperacillin/tazobactam(61.1%),while the drugs sensitive to Gram-positive cocci were vancomycin(100%) and nitrofurantion(92.9%).Drug resistance for ESBL(+)Gram-negative bacilli and MRSA obviously increased(P0.05).Conclusions The main pathogen of lung infection after tracheotomy in the hospital is Gram-negative bacilli.Antibiotic resistance of bacteria becomes severe.Phlegm cultivation and drug sensitivity testing should be actively developed in the clinic.
出处 《山东大学耳鼻喉眼学报》 CAS 2012年第2期66-68,共3页 Journal of Otolaryngology and Ophthalmology of Shandong University
关键词 气管切开 肺部感染 病原学 Tracheotomy Iatrogenic lung infection Etiology
  • 相关文献

参考文献8

二级参考文献31

  • 1中华医学会呼吸病学会.医院内获得性支气管-肺感染诊断标准(试行草案)[J].中华结核和呼吸杂志,1990,(13):372-374.
  • 2[1]Jacoby GA,Mederiros AA. More extended-spectrum β-lactamases[J]. Antimicrob Agents Chemother,1991, 35(9):1697-1704.
  • 3[4]Sanders CC,Barry AL, Washington JA, et al. Detection of extended-spectrum β-lactamases-producing members of the family Enterobacteriaceae with the VITEK ESBLs test [J]. J Clin Microbiol, 1996,34(12): 2997-3001.
  • 4[5]Livermore DM. β-Lactamases in laboratory and clinical resistance [J]. J Clin Microbiol Rev, 1995, 8(3): 557-584.
  • 5[6]National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement [S]. NCCLS, 1999.19: 36-75.
  • 6[9]Rasmussen BA, Bush K. Carbapenem-hydrolyzing β-lactamases [J]. Antimicrob Agents Chemother, 1997, 41(2): 223-232.
  • 7[10]Coudron PE, Molaand ES, Thomoson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center[J]. J Clin Microbiol, 2000, 38(5):1791-1796.
  • 8[11]Jacoby GA, Han P. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli [J]. J Clin Microbiol, 1996, 34(4): 908-911.
  • 9Graven DE, Steger KA. Ventilator- associated bacterial pneumonia:challenges in diagnosis, treatment, and prevention[J]. New Horiz,1998,6(2 Suppl) :S30 - S45.
  • 10杨维,李成林,张乃崇,蒯增芝.1863 例神经外科住院患者医院感染回顾性分析[J].中华医院感染学杂志,1997,7(2):91-92. 被引量:40

共引文献400

同被引文献7

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部